Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2025-05-17 Annual Report
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed announcement from Neogen Chemicals Limited regarding the outcome of a Board Meeting held on May 17, 2025. It includes approval of audited financial results for the quarter and financial year ended March 31, 2025, along with the audit reports. The document contains an Independent Auditor's Report on the audit of standalone annual financial results pursuant to SEBI regulations, with detailed auditor opinions, management responsibilities, and audit scope. The presence of full audited financial results and the auditor's detailed report indicates this is the official annual report covering the company's full financial performance for the fiscal year. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K).
2025-05-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is an official communication from Neogen Chemicals Limited dated May 14, 2025, addressed to stock exchanges and investors. It announces the schedule of an Earnings Conference Call to discuss the Q4 FY25 financial results. The document includes an invitation to the call and mentions that the call will feature a management discussion followed by a Q&A session. There is no actual financial data or detailed financial report included in the text; rather, it is an announcement of the upcoming earnings call event. According to the classification rules, announcements of earnings calls or schedules are classified as Call Transcript (CT) only if they contain the full transcript. Since this document is only an announcement of the call schedule and invitation, it fits best under the category of Call Transcript (CT) as it relates directly to the earnings call event. However, since it does not contain the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement about the earnings call schedule pursuant to SEBI regulations. But given the options and the nature of the document, the best fit is Call Transcript (CT) as it is specifically about the earnings conference call for Q4 FY25 results. Confidence is high due to clear references to earnings call and Q4 FY25 results discussion.
2025-05-14 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-14 English
Board Meeting — Financial Results/Dividend
Board/Management Information Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled for May 17, 2025, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2025, and to recommend a final dividend. It is an intimation to stock exchanges pursuant to SEBI Listing Regulations. The document does not contain the financial results themselves but announces the meeting where these results will be approved. The document length is short (2268 characters) and serves as a formal announcement rather than a report. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related corporate governance events.
2025-05-14 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 10(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details an inter-se transfer of shares among promoters of Neogen Chemicals Limited, with no change in aggregate promoter holding. The document includes compliance details, fees paid to SEBI, and acknowledgments related to the takeover regulations. It is a regulatory disclosure about shareholding changes and compliance with takeover rules, not a financial report, earnings release, or management discussion. It is not a report publication announcement or certification but a formal regulatory filing to stock exchanges and SEBI. Therefore, it fits best under Regulatory Filings (RNS).
2025-05-03 English
General Updates
Regulatory Filings Classification · 100% confidence The document is a disclosure under Regulation 10(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details an inter-se transfer of shares among promoters, with no change in aggregate promoter holding. The document includes compliance details, dates of filings, and payment of fees to SEBI. It is a regulatory disclosure about share acquisition and transfer, not a financial report, earnings release, or management discussion. It does not contain financial statements or management commentary but is a formal regulatory filing to stock exchanges and SEBI. Therefore, it fits the category of Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive regulatory disclosure.
2025-05-02 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.